Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue (original) (raw)
Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase
Dinesh Patel
Drug Development Research, 1995
View PDFchevron_right
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice
Scott Mosser
Proceedings of the National Academy of Sciences, 1994
View PDFchevron_right
Farnesyl Diphosphate-Based Inhibitors of Ras Farnesyl Protein Transferase
Veeraswamy Manne
Journal of Medicinal Chemistry, 1995
View PDFchevron_right
C-Terminal Modifications of Histidyl- N -benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice
Barbara Gibbs, Scott Bur
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Hydrophilic Anilinogeranyl Diphosphate Prenyl Analogues Are Ras Function Inhibitors †
Kareem Chehade
Biochemistry
View PDFchevron_right
Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignancies
Judith Karp
Seminars in Hematology, 2001
View PDFchevron_right
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
Channing Der
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
View PDFchevron_right
RPR 130401, a Nonpeptidomimetic Farnesyltransferase Inhibitor with in Vivo Activity
Patrick Mailliet
Annals of the New York Academy of Sciences, 1999
View PDFchevron_right
Design and Synthesis of a Transferable Farnesyl Pyrophosphate Analogue to Ras by Protein Farnesyltransferase
Douglas Andres
The Journal of Organic Chemistry, 2000
View PDFchevron_right
Farnesyltransferase inhibitors versus Ras inhibitors
Charles Omer
Current Opinion in Chemical Biology, 1997
View PDFchevron_right
Inhibitors of Farnesyl Protein Transferase and MEK1,2 Induce Apoptosis in Fibroblasts Transformed with Farnesylated but Not Geranylgeranylated H-Ras
Diana Brassard
Experimental Cell Research, 2002
View PDFchevron_right
Inhibition of human tumor cell growthIn vitro andIn vivo by a specific inhibitor of human farnesyltransferase: BIM-46068
Gilles Favre
International Journal of Cancer, 1999
View PDFchevron_right
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor
Veeraswamy Manne
Cancer research, 2001
View PDFchevron_right
A novel class of highly potent, selective, and non-peptidic inhibitor of ras farnesyltransferase (FTase)
Jin-ho Lee
Bioorganic & Medicinal Chemistry Letters, 2001
View PDFchevron_right
Inhibition of human tumor cell growthin vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228
Gilles Favre
International Journal of Cancer, 2001
View PDFchevron_right
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units
Elzbieta Izbicka
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 1999
View PDFchevron_right
Farnesyl Transferase Inhibitors as Potential Anticancer Agents
Sounak Bagchi
Mini Reviews in Medicinal Chemistry, 2018
View PDFchevron_right
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
Stacy Remiszewski
Cancer research, 1998
View PDFchevron_right
Synthesis, Biochemical, and Cellular Evaluation of Farnesyl Monophosphate Prodrugs as Farnesyltransferase Inhibitors
Torben Borchert, Patricia Mathieu
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Tailoring Ras-pathway—Inhibitor combinations for cancer therapy
Roy Blum
Drug Resistance Updates, 2005
View PDFchevron_right
Structure−Activity Relationship of 3-Substituted N -(Pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11 H -benzo[5,6]cyclohepta[1,2- b ]pyridin-11-ylidene)- piperidine Inhibitors of Farnesyl-Protein Transferase: Design and Synthesis of in Vivo Active Antitumor Compounds
George Njoroge
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy
Alfredo Cesario
Letters in Drug Design & Discovery, 2005
View PDFchevron_right
Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid
Daniele Marciano
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1999
View PDFchevron_right
Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro
Alison Todd
Cancer research, 2001
View PDFchevron_right
Apoptotic and Cytostatic Farnesyltransferase Inhibitors Have Distinct Pharmacology and Efficacy Profiles in Tumor Models
Little Bear Lx
2004
View PDFchevron_right